Skip to content

Application and effects of comprehensive geriatric assessment in patients with newly diagnosed hematological malignancies

Application and effects of comprehensive geriatric assessment in patients with newly diagnosed hematological malignancies

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033804
Enrollment
Unknown
Registered
2020-06-13
Start date
2020-06-15
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Leukaemia, Lymphoma, Multiple Myeloma, Myelodysplasic syndrome

Interventions

Acute Leukaemia group:Nil
Multiple Myeloma group:Nil
Myelodysplasic syndrome group:Nil

Sponsors

The First Affiliated Hospital of Zhejiang University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with acute leukemia, lymphoma, multiple myeloma and myelodysplastic syndromes; 2. Patients aged >= 18 years; 3. Patients with clear consciousness, physical condition and certain understanding ability; 4. Ask the informed consent of patients and their families to participate in the research voluntarily.

Exclusion criteria

Exclusion criteria: 1. Patients who have received anti-tumor treatment or relapse; 2. Patients who are illiterate or unable to understand and complete the test; 3. Patients with severe mental illness.

Design outcomes

Primary

MeasureTime frame
CGA;

Countries

China

Contacts

Public ContactSun Caihong

The First Affiliated Hospital of Zhejiang University Medical College

603421301@qq.com+86 13588820112

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026